Advertisement
Advertisement

PRLD

PRLD logo

Prelude Therapeutics Incorporated

4.27
USD
Sponsored
-0.11
-2.51%
Jun 24, 16:00 UTC -4
Closed
exchange

Pre-Market

4.51

+0.24
+5.62%

Prelude Therapeutics Incorporated Financial Snapshot

Market Cap
359.20M
Beta
0.73
Earnings Per Share (EPS)
-1.29
Price-to-Book (P/B) Ratio
4.04
Operating Margin
--
Total Debt/Equity (D/E)
0.00%
P/E Ratio
--
Return on Equity (ROE)
-129.98%
Current Ratio
1.99%
Free Cash Flow
-56.37M

Earnings Chart

Advertisement